Imaxio, a biotech company based in Lyon, specializing in protein engineering for immunotherapy, has just signed a worldwide licensing agreement with the American company Wyeth and the Massachusetts General Hospital in Boston.
Imaxio signed a worldwide licensing agreement with Wyeth and the Massachusetts General Hospital (Boston)